The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Kurt Geiger general counsel Suzanne Smith is to leave the company to return to the pharmaceuticals sector, joining global biotechnology corporation Genzyme.
Smith joined Kurt Geiger a year ago from pharma company Phoqus Pharmaceuticals, where she was general counsel. She joined Phoqus in February 2005 and was appointed company secretary in January 2007.
Smith will join US company Genzyme later this year as legal director for the UK and Ireland, a role that has been created for her. The biotechnology company headhunted her for the position.
Genzyme has more than 11,000 employees in locations across the globe, including four offices in the UK and one in Ireland.
It develops products and services that focus on rare inherited disorders, including kidney disease, orthopaedics, cancer, transplant and immune disease, as well as diagnostic testing.
Kurt Geiger is currently looking for a replacement.